x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Beyond Biotech - the podcast from Labiotech

Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what"s happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.

news tech news

All Episodes

29:17

Developing treatments for rare pediatric diseases

Beyond Biotech - the podcast from Labiotech ·

2024/06/07

Rare diseases affect around 1 in 2,000 people. Many of the thousands of rare diseases are difficult to diagnose. Of the known rare diseases, about 80% have genetic causes. Leukodystrophies are a group of rare genetic disorders for which there is currently no curative therapy.This week on the podcast we are discussing novel treatments of rare pediatric diseases in a conversation with Dan Williams, CEO, executive director and co-founder of Synaptix Bio. Synaptix Bio is working on developi...

en-us

31:00

Can cell therapy tackle hearing loss?

Beyond Biotech - the podcast from Labiotech ·

2024/05/31

Hearing loss is a huge – and growing – global challenge.Using its OSPREY platform, UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss, a significant global medical challenge. The company’s lead asset, Rincell-1, is designed to regenerate auditory neurons and provide a novel treatment for patients with severe-to-profound age-related hearing loss or auditory neuropathy. The company is looking to st...

en-us

28:50

How biotech is tackling myasthenia gravis

Beyond Biotech - the podcast from Labiotech ·

2024/05/24

June is myasthenia gravis awareness month. Myasthenia gravis is a chronic autoimmune disorder where antibodies destroy the communication between nerves and muscle, and this results in weakness of the skeletal muscles. It especially affects the voluntary muscles of the eyes, mouth, throat and/or limbs. It is most frequent in women from 20 and 30 and men aged 50 and older. To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a c...

en-us

27:22

Antisense oligonucleotides

Beyond Biotech - the podcast from Labiotech ·

2024/05/17

German-headquartered Isarna Therapeutics is developing a portfolio of antisense therapies targeting an emerging therapeutic field in human biology – transforming growth factor beta (TGF-B) signaling. Precise modulation of TGF-B pathways using antisense therapy may result in safer and more effective treatment options for a broad range of indications.The company’s lead compound, ISTH0036, is in clinical development in ophthalmology.On the podcast this week we chat with René Rückert, chief opera...

en-us

21:02

Making waves in cardiovascular disease treatment

Beyond Biotech - the podcast from Labiotech ·

2024/05/10

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised.This week, we have a conversation with the CEO of Cytokinetics, Robert Blum, about the company’s aficamten, its next-in-class cardiac myosin inhibitor, prior to results from a phase 3 clinica...

en-us

23:56

New ways to treat Duchenne muscular dystrophy

Beyond Biotech - the podcast from Labiotech ·

2024/05/03

en-us

26:00

Overcoming clinical trial challenges

Beyond Biotech - the podcast from Labiotech ·

2024/04/26

en-us

28:32

The biotech investment landscape in 2024

Beyond Biotech - the podcast from Labiotech ·

2024/04/19

en-us

35:42

Redefining chronic pain treatment

Beyond Biotech - the podcast from Labiotech ·

2024/04/12

en-us

38:24

Colossal aims to bring back mammoth by 2028

Beyond Biotech - the podcast from Labiotech ·

2024/04/05

en-us

25:31

New treatments being developed for schizophrenia

Beyond Biotech - the podcast from Labiotech ·

2024/03/22

en-us

41:37

Reformulating psychedelics for neurodegenerative...

Beyond Biotech - the podcast from Labiotech ·

2024/03/15

en-us

28:46

How AI immune system mapping can boost drug discovery

Beyond Biotech - the podcast from Labiotech ·

2024/03/08

en-us

33:11

Is Tome writing the final chapter in genomic medicine?

Beyond Biotech - the podcast from Labiotech ·

2024/03/01

en-us

41:27

Transforming treatments for epilepsy

Beyond Biotech - the podcast from Labiotech ·

2024/02/23

en-us

38:26

How does AI assist drug discovery?

Beyond Biotech - the podcast from Labiotech ·

2024/02/16

en-us

37:17

Biosimilars and what’s new in cell and gene therapies

Beyond Biotech - the podcast from Labiotech ·

2024/02/09

en-us

31:43

BioSenic developing severe knee osteoarthritis treatment

Beyond Biotech - the podcast from Labiotech ·

2024/02/02

en-us

32:38

Boosting fertility by changing the vaginal microbiome

Beyond Biotech - the podcast from Labiotech ·

2024/01/26

en-us

32:43

Epic Bio - gene editing without cutting DNA

Beyond Biotech - the podcast from Labiotech ·

2024/01/19

en-us

180 results

Similar Podcasts

Expres Ráno

Expres FM

PBS News Hour - Full Show

PBS News

CD Voice

China Daily

Israel Today: Ongoing War Report

Noa Levi

Jeffrey Epstein: The Coverup Chronicles

Bobby Capucci